|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Exact Sciences Corporation |
EXAS |
30063P105 |
684 |
$70,794.00 |
3.60% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
705 |
$61,405.50 |
3.13% |
| Align Technology, Inc. |
ALGN |
016255101 |
317 |
$55,158.00 |
2.81% |
| Penumbra, Inc. |
PEN |
70975L107 |
153 |
$51,811.92 |
2.64% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$51,593.26 |
2.63% |
| Masimo Corporation |
MASI |
574795100 |
276 |
$48,415.92 |
2.46% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
93 |
$45,584.88 |
2.32% |
| Alcon Inc. |
ALC.SW |
H01301128 |
552 |
$44,939.32 |
2.29% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,917 |
$44,863.77 |
2.28% |
| Waters Corporation |
WAT |
941848103 |
148 |
$44,775.91 |
2.28% |
| Hologic, Inc. |
HOLX |
436440101 |
589 |
$44,610.86 |
2.27% |
| The Cooper Companies, Inc. |
COO |
216648501 |
583 |
$44,628.65 |
2.27% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
539 |
$44,003.96 |
2.24% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,452 |
$41,990.91 |
2.14% |
| DexCom, Inc. |
DXCM |
252131107 |
612 |
$41,677.20 |
2.12% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
562 |
$41,739.74 |
2.12% |
| Revvity, Inc. |
RVTY |
714046109 |
452 |
$41,285.68 |
2.10% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
369 |
$40,451.75 |
2.06% |
| Stryker Corporation |
SYK |
863667101 |
109 |
$39,737.04 |
2.02% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
421 |
$39,620.31 |
2.02% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,785 |
$39,296.41 |
2.00% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,263 |
$38,979.54 |
1.98% |
| Steris Plc |
STE |
G8473T100 |
169 |
$38,956.19 |
1.98% |
| Danaher Corporation |
DHR |
235851102 |
197 |
$38,513.50 |
1.96% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
76 |
$38,149.72 |
1.94% |
| Medtronic Plc |
MDT |
G5960L103 |
418 |
$37,996.20 |
1.93% |
| Teleflex Incorporated |
TFX |
879369106 |
334 |
$37,845.54 |
1.93% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
31 |
$37,499.15 |
1.91% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
152 |
$37,370.72 |
1.90% |
| ResMed Inc. |
RMD |
761152107 |
147 |
$37,171.89 |
1.89% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
505 |
$36,693.30 |
1.87% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
147 |
$36,423.29 |
1.85% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
134 |
$36,159.90 |
1.84% |
| Becton, Dickinson and Company |
BDX |
075887109 |
214 |
$35,763.68 |
1.82% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
184 |
$35,361.95 |
1.80% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
729 |
$34,382.24 |
1.75% |
| Agilent Technologies, Inc. |
A |
00846U101 |
292 |
$33,600.44 |
1.71% |
| BioMerieux |
BIM.FP |
F1149Y232 |
300 |
$33,316.68 |
1.70% |
| Abbott Laboratories |
ABT |
002824100 |
301 |
$32,977.56 |
1.68% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,129 |
$33,022.39 |
1.68% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
455 |
$32,895.22 |
1.67% |
| Baxter International Inc. |
BAX |
071813109 |
1,817 |
$32,142.73 |
1.64% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,460 |
$31,710.34 |
1.61% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,234 |
$31,239.98 |
1.59% |
| Insulet Corporation |
PODD |
45784P101 |
127 |
$30,100.27 |
1.53% |
| Boston Scientific Corporation |
BSX |
101137107 |
418 |
$29,824.30 |
1.52% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,331 |
$28,560.79 |
1.45% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,240 |
$27,615.82 |
1.41% |
| Cochlear Limited |
COH.AU |
Q25953102 |
215 |
$26,893.17 |
1.37% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
805 |
$23,593.95 |
1.20% |
| US Dollar |
$USD |
|
1,658 |
$1,657.59 |
0.08% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|